SCHEMBL10185553

SCHEMBL10185553

O=C(C(=O)N(c1cccc(F)c1)C1C(=O)N(C2CCCCC2)c2ccccc21)c1c[nH]c2ccncc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HTR1A P08908 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HSD11B1 P28845 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ HPGD P15428 1/20 0.32
▸ KDM4C Q9H3R0 2/20 0.32
▸ OPRM1 P35372 3/20 0.32
▸ OPRK1 P41145 3/20 0.32
▸ OPRL1 P41146 3/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ KDM5A P29375 1/20 0.31
▸ KDM5B Q9UGL1 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ CDK4 P11802 1/20 0.31
▸ CCND1 P24385 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183922 0.82 HTR1A (0.36) HTR1ADRD2HTR2AHSD11B1KMT2A
SCHEMBL10183227 0.78 MAPT (0.42) HTR1ADRD2HTR2AALDH1A1KMT2A
SCHEMBL10185583 0.77 OPRM1 (0.35) HTR1ADRD2HTR2AALDH1A1KMT2A
SCHEMBL10185957 0.76 TSHR (0.43) CYP3A4CYP2C19ALDH1A1KMT2AOPRM1
SCHEMBL10183299 0.75 OPRM1 (0.40) OPRM1OPRK1OPRL1MAPT
SCHEMBL10184008 0.74 PTGIR (0.38) CYP3A4CYP2C19ALDH1A1OPRM1OPRK1
SCHEMBL10183319 0.74 MEN1 (0.43) ALDH1A1KMT2AOPRM1OPRK1OPRL1
SCHEMBL10183337 0.74 OPRM1 (0.39) KMT2AOPRM1OPRK1OPRL1NPC1
SCHEMBL10185933 0.73 GRM5 (0.40) KMT2AOPRM1OPRK1OPRL1MEN1
SCHEMBL10183615 0.73 RORC (0.36) OPRM1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback